Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.

TLDR

The authors introduced a doxycycline‑inducible tet regulatory system controlling RNA polymerase II promoters into transgenic mice. The system achieved tight, dose‑dependent regulation spanning five orders of magnitude, with rapid luciferase induction within hours, liver‑specific activation exceeding 10⁵‑fold in the absence of doxycycline and minimal expression when induced, demonstrating precise, tissue‑specific gene control in transgenic mice.

Abstract

The tet regulatory system in which doxycycline (dox) acts as an inducer of specifically engineered RNA polymerase II promoters was transferred into transgenic mice. Tight control and a broad range of regulation spanning up to five orders of magnitude were monitored dependent on the dox concentration in the water supply of the animals. Administration of dox rapidly induces the synthesis of the indicator enzyme luciferase whose activity rises over several orders of magnitude within the first 4 h in some organs. Induction is complete after 24 h in most organs analyzed. A comparable regulatory potential was revealed with the tet regulatory system where dox prevents transcription activation. Directing the synthesis of the tetracycline-controlled transactivator (tTA) to the liver led to highly specific regulation in hepatocytes where, in presence of dox, less than one molecule of luciferase was detected per cell. By contrast, a more than 10(5)-fold activation of the luciferase gene was observed in the absence of the antibiotic. This regulation was homogeneous throughout but stringently restricted to hepatocytes. These results demonstrate that both tetracycline-controlled transcriptional activation systems provide genetic switches that permit the quantitative control of gene activities in transgenic mice in a tissue-specific manner and, thus, suggest possibilities for the generation of a novel type of conditional mutants.